Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers
Authors:
- Misael UribeMUMisael Uribe
- Carlos CasianCCCarlos Casian
- Sonia RojasSRSonia Rojas
- Joség. SierraJSJoség. Sierra
- Vian L.W. GoVGVian L.W. Go
- M.A. RosaMRM.A. Rosa
- MuñozMUMuñoz
- Sofia GilSGSofia Gil
- 1 April 1981
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 80 (4) , 661-665
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.British Journal of Clinical Pharmacology, 1979
- Corticosteroid Pharmacokinetics in Liver DiseaseClinical Pharmacokinetics, 1979
- Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.Gut, 1978
- Peptic Ulcer, Prednisone and Serum Gastrin in Chronic Active Liver DiseaseNew England Journal of Medicine, 1977
- Decreased Bioavailability of Digoxin Due to Antacids and Kaolin-PectinNew England Journal of Medicine, 1976
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- The uptake of digoxin and digitoxin by some antacidsJournal of Pharmacy and Pharmacology, 1974
- Influence of Sodium Taurocholate, Cholestyramine, and Mylanta on the Intestinal Absorption of Glucocorticoids in the RatGastroenterology, 1973
- Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in manClinical Pharmacology & Therapeutics, 1973
- Absorption of Steroid Hormones from the Human Small Intestine1The Journal of Clinical Endocrinology & Metabolism, 1965